Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,396.80
(
0.36%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.28
(
6.58%
)
Bitcoin
75,590.78
(
-0.99%
)
News Focus
News Focus
Post# of 257466
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122906
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 245474

Tuesday, 01/30/2024 9:34:05 AM

Tuesday, January 30, 2024 9:34:05 AM

Post# of 257466
TSVT sells all_assets_other_than Abecma to REGN for $5M(!?) plus an undisclosed contingent payment:

https://finance.yahoo.com/news/1-2seventy-bio-sell-experimental-123259198.html

TSVT is the 2021 oncology spinoff from BLUE (#msg-166641248). BMY is TVST’s partner for the development and commercialization of Abecma.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today